home / stock / cyth / cyth news

CYTH News and Press, Cyclo Therapeutics Inc. From 02/05/21

Stock Information
Company Name: Cyclo Therapeutics Inc.
Stock Symbol: CYTH
Market: NASDAQ
Website: cyclodex.com
Menu
CYTH CYTH Quote CYTH Short CYTH News CYTH Articles CYTH Message Board
Get CYTH Alerts

News, Short Squeeze, Breakout and More Instantly...
CYTH - T2 Biosystems, Zomedica leads healthcare gainers; Pro-Dex, Veru among major losers

Gainers: T2 Biosystems (TTOO) +30%, Zomedica (ZOM) +24%, Sientra (SIEN) +18%, Misonix (MSON) +18%, Senseonics (SENS) +17%.Losers: Pro-Dex (PDEX) -22%, Veru (VERU) -21%, Twist Bioscience TWST -20%, Spero Therapeutics SPRO -19%, C...
CYTH - PTON ,U among premarket losers

ATA Creativity Global AACG -41% pared down yesterday's gain as Reddit users pump.Document Security Systems DSS -32% after pricing equity offering.Midatech Pharma (MTP) -21%.Twist Bioscience TWST -17% after JPMorgan downgrade.FirstMark Horizon Acquisition (FMAC) -...

CYTH - Anavex and Cyclo are extending the Alzheimer's-driven rally

Anavex Life Sciences (AVXL) and Cyclo Therapeutics (CYTH) are continuing the momentum following the announcement by Cassava Sciences (NASDAQ:SAVA) on Tuesday that its lead asset simufilam generated positive interim data in an open-label study.Though Cassava has reversed the gains with a ...

CYTH - AVXL, GME, ATOS and BTU among midday movers

Gainers: ATA Creativity Global (AACG) +204%.Anavex Life Sciences (AVXL) +81%.Lizhi (LIZI) +76%.CPS Technologies (CPSH) +48%.Annovis Bio (ANVS) +43%.Sify Technologies (SIFY) +42%.Tian Ruixiang (TIRX) +40%.Cyclerion Therapeutics (CYCN) +39%.Cyclo Therapeutics (CYTH) +33%.Ato...
CYTH - Anavex Life Sciences, Annovis Bio leads healthcare gainers; Tyme Technologies, Isoray among major losers

Gainers: Anavex Life Sciences (AVXL) +94%, Annovis Bio (ANVS) +50%, Atossa Therapeutics (ATOS) +40%, Cyclerion Therapeutics (CYCN) +40%, Cyclo Therapeutics (CYTH) +33%.Losers: Tyme Technologies (TYME) -36%, Isoray (ISR) -19%, Lannett...

CYTH - MNKD, APPS, SAVA and GOOS among premarket gainers

ATA Creativity Global (AACG) +163%.Anavex Life Sciences (AVXL) +83%.Profire Energy (PFIE) +57%.Theratechnologies (THTX) +56% on FDA fast track designation for the treatment of Sortilin-expressing Cancers.Cyclerion Therapeutics (CYCN) +34%.Atossa Therapeutics (ATOS) +33%.Enservco Corporat...

CYTH - Cyclo Therapeutics to Present on Its Clinical and Drug Development Program for Lead Candidate, Trappsol® Cyclo(TM), at WORLDSymposium 2021

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of Neurodegenerative Diseases, including their lead candidate (Trappsol ® ...
CYTH - Cyclo Therapeutics' lead candidate shows durable benefit in Niemann-Pick Disease

Thinly-traded nano-cap Cyclo Therapeutics (CYTH) soars 55% in premarket on initial data from its open-label study of long-term safety and efficacy of intravenous Trappsol Cyclo, its lead candidate, for the treatment of Niemann-Pick Disease Type C ((NPC)), a rare ...

CYTH - CHU, CHL, FUBO and SKLZ among premarket gainers

Aileron Therapeutics (ALRN) +73%.Broadway Financial Corporation (BYFC) +55% after regulatory approvals for merger with CFBanc Corporation.Atlantic American Corporation (AAME) +43%.Marker Therapeutics (MRKR) +30% after FDA lifted the partial clinical hold on it's Phase 2 trial.Cyclo ...

CYTH - Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with Trappsol® Cyclo(TM) in Patients with Niemann-Pick Disease Type C

Home-based intravenous infusions of Trappsol® Cyclo™ for up to one year show improvement in disease features or disease stabilization Cyclo Therapeutics, Inc. (NasdaqCM:CYTH) (NasdaqCM:CYTHW), a clinical stage biotechnology company developing a cyclodextrin platf...
Previous 10 Next 10